In June 2006, a 77-year-old Japanese man (YH001) with an acute asthma attack was admitted to our hospital in Yokohama, Japan. A pre-admission HIV screening test by enzyme immunoassay unexpectedly detected his HIV seropositivity. The confirmatory Western blotting (Lab-blot 1 and 2, Bio-Rad Fujirebio, Tokyo, Japan) showed strong seroreactivity to HIV-2, but not to HIV-1. Furthermore, peptide immunoassay (Peptilav, Sanofi Diagnostics Pasteur, Marnes-La-Coquette, France) and type-specific particle agglutination tests (Serodia-HIV-1/2, Bio-Rad Fujirebio) unequivocally confirmed HIV-2 infection. He had no history of engaging in high risk sexual contact and substance abuse in the past. Both his spouse (72 years old) and their son (34 years old) were HIV-negative. He, however, had a near-fetal motor accident in Senegal in June 1971 and underwent emergent splenectomy. During the operation, he received a large unit of blood from a number of volunteer Senegalian donors. He has never been transfused with blood products except on that occasion. After admission, his chest X-ray and multislice computed tomography showed a bilateral reticulonodular shadow that was similar to the shadow of diffuse panbronchiolitis; however, there were no specific signs of pulmonary manifestation related to AIDS, such as pulmonary tuberculosis, Pneumocystis carinii pneumonia and the other indicator diseases. After treatment with pazufloxacin, his chest X-ray shadow was improved. After 8 days, he was discharged from hospital after recovering from an asthma attack by treatment with steroid therapy. His CD4 cell count was 827 cells/μl. There does not appear to have been a causal relationship between the attack and HIV infection. He continues to be long-term nonprogressor with respect to observation of the clinical course after discharge. To investigate how he acquired HIV-2, we amplified and determined the nucleotide sequence of HIV-2 gag p17–p24 region (nucleotide position 1123–1598 of BEN) from the proviral DNA in peripheral blood nuclear cells. As shown in Fig. 1, YH001 belongs to HIV-2 group A, which is known to be distributed in western part of West Africa. In particular, YH001 showed a close relationship to the HIV-2 strain (60415K) from Senegal [1] (Fig. 1). This is consistent with the patient's history of exposure to HIV through blood transfusion in Senegal in 1971.Fig. 1: Neighbor-joining tree analysis of gag p17–p24 region (nucleotide position 1123–1598 of HIV-2 reference strain BEN) of the HIV-2 genes from the first Japanese case (YH001) with the reference sequences for the respective HIV-2 groups (A–E, G). The numbers on the nodes represent the percentage of bootstrap values with which the cluster is supported; only those values greater than 80% are shown. YH001 (arrowed) is closely related to HIV-2 reference strain 60415K, which is a strain isolated from an asymptomatic male patient in 1993 in Senegal [1].In Japan, two cases of HIV-2 infection had been documented by 2001 [2]. Since both are cases of Korean nationality, this is the first report of HIV-2 infection identified in a Japanese individual. It is known that HIV-2-infected individuals exhibit longer clinical latency and a slower disease progression than HIV-1 [3]. For HIV-1, the median incubation period is estimated at approximately 10 years. Although there was no cohort study to estimate the clinical latency of HIV-2 infection, the early literature reports that a Portuguese man infected in Guinea-Bissau had a clinical latency period of 16–19 years (1966/1969–1985) [4]. The mortality rate in HIV-2-infected patients is reported to be approximately two-thirds of that in HIV-1-infected patients [5]. One study reported that a Portuguese woman infected with HIV-2 through blood transfusion had been asymptomatic for 27 years (1967–1994) [6]. Our patient shows no signs of AIDS after 36 years of infection and remains asymptomatic as of March 2007 without any treatment. He is the longest asymptomatic survivor with HIV-2 infection. An investigation on the factors behind the his long-term survival is now in progress.
Read full abstract